Manufacturer record
Scott-Edil Pharmacia Ltd: regulatory record
Last checked 20 September 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories
17 batches manufactured by Scott-Edil Pharmacia Ltd (Himachal Pradesh) were declared Not of Standard Quality between January 2019 and June 2026. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.
Records by type
17 records linked to Scott-Edil Pharmacia Ltd in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.
CDSCO drug alerts: Not of Standard Quality and spurious drugs
Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.
Flagged batches per year
All flagged batches
| Product | Batch | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|
| Bisacodyl gastro-resistant Tablets IP | 2518853T002Mfg 2025-06 · Exp 2028-05 | Sample does not conform to IP 2022 standards. This particular batch sample fails the test DissolutionDissolution | RDTL, ErnakulamState lab | Jun 2026 |
| Bisacodyl Gastro Resistant Tablets IP | 2518853T001Mfg 2025-01 · Exp 2027-12 | The sample does not conform to IP 2022 requirements w.r.t Dissolution TestDissolution | DTL,Dalgate Srinagar kashmirState lab | May 2026 |
| Diphenhydramine Hydrochloride, Ammonium Chloride, Sodium Citrate & Menthol Syrup | 2519031L002Mfg 2025-12 · Exp 2027-11 | The sample does not conform to claim as per Patent and Proprietary in respect to the Assay of Sodium Citrate.Assay | RDTL, ChandigarhCDSCO lab | Feb 2026 |
| Voligesic Gel (Diclofenac Diethylamine. Linseed Oil, Methyl Salicylate & Menthol Gel) | DE4G12Mfg 2024-07 · Exp 2027-06 | ContentOther | Drugs Testing Laboratory, Madurai-19State lab | Oct 2025 |
| Bisacodyl Gastro- Resistant Tablets IP (Edilax) | 2418853T003Mfg 2024-06 · Exp 2027-05 | Does not comply with respect to test for DisintegrationDisintegration | State Lab PuducherryState lab | Apr 2025 |
| Heparin Sodium Injection IP 25000 IU / 5 ml | GV3H001Mfg 2023-08 · Exp 2026-07 | pH, Particulate Matter, DescriptionDescription | CDL KolkataCDSCO lab | Nov 2024 |
| Heparin Sodium Injection IP 25000 IU / 5 ml | GV3E001Mfg 2023-05 · Exp 2026-04 | pH, Particulate Matter, Assay of Heparin (Anti- factor Iia activity), DescriptionAssay | CDL KolkataCDSCO lab | Nov 2024 |
| Adrenaline Injection IP 1.8mg/ml (Adrenascot) | GA3A020Mfg 2023-01 · Exp 2024-12 | Appearance of Solution and DescriptionDescription | RDTL GuwahatiCDSCO lab | Oct 2024 |
| Metformin Hydrochloride Sustained-release Tablets IP (Glycimet-SR-500) | GT3J023Mfg 2023-10 · Exp 2025-09 | Dissolution of Metformin HydrochlorideDissolution | CDL KolkataCDSCO lab | Aug 2024 |
| Heparin Sodium Injection IP 25000 IU / 5ml | GV3C002Mfg 2023-03 · Exp 2026-02 | Description & Particulate MatterDescription | CDL KolkataCDSCO lab | Aug 2024 |
| Paracetamol Tablets I.P. 500 Mg. | GT2G030Mfg 2022-07 · Exp 2025-06 | DissolutionDissolution | RDTL GuwahatiState lab | Oct 2023 |
| Bisacodyl Tablets IP (Dulax Tablets) | DT2H005Mfg 2022-08 · Exp 2025-07 | AssayAssay | RDTL ChandigarhCDSCO lab | Nov 2022 |
| Amlodipine Tablets IP (AMLOTIS-10 TABLETS) | 2113452T001Mfg 2021-06 · Exp 2023-05 | AssayAssay | RDTL ChandigarhCDSCO lab | May 2022 |
| Meropenem Injection IP 500 mg (MEROMAX 500 MG INJECTION) | DP1013Mfg 2021-05 · Exp 2023-04 | Particulate matterParticulate matter | RDTL ChandigarhCDSCO lab | Oct 2021 |
| Amikacin Injection I.P. 2ml | GV1A001Mfg 2021-01 · Exp 2022-12 | Description & Particulate MatterDescription | CDL KolkataCDSCO lab | Oct 2021 |
| Fluconazole Tablets IP (FLUTIS-150 TABLETS) | SDS874Mfg 2018-05 · Exp 2020-04 | DissolutionDissolution | RDTL ChandigarhCDSCO lab | May 2019 |
| Amoxycillin And Potassium Clavulanate Tablets I.P. | SB58049Mfg 2018-03 · Exp 2020-02 | Assay of Amoxycillin, Assay of Clavulanic Acid & DissolutionAssay | RDTL GuwahatiState lab | Jan 2019 |
Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.